West Pharmaceutical Services (NYSE:WST – Get Free Report) posted its earnings results on Thursday. The medical instruments supplier reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.34, Briefing.com reports. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The business had revenue of $746.90 million for the quarter, compared to the consensus estimate of $709.62 million. During the same quarter last year, the firm posted $2.16 EPS. The company’s revenue for the quarter was down .1% on a year-over-year basis. West Pharmaceutical Services updated its FY 2024 guidance to 6.550-6.750 EPS and its FY24 guidance to $6.55 to $6.75 EPS.
West Pharmaceutical Services Stock Down 6.9 %
Shares of NYSE WST opened at $307.92 on Friday. West Pharmaceutical Services has a 12-month low of $265.00 and a 12-month high of $413.70. The stock’s fifty day simple moving average is $300.51 and its two-hundred day simple moving average is $321.78. The stock has a market capitalization of $22.43 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 10.21 and a beta of 1.01. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03.
West Pharmaceutical Services Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be paid a $0.21 dividend. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. West Pharmaceutical Services’s payout ratio is 11.08%.
Insider Transactions at West Pharmaceutical Services
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Articles
- Five stocks we like better than West Pharmaceutical Services
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Using the MarketBeat Stock Split Calculator
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is Put Option Volume?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.